Gimv

The Spice Factory is a manufacturer specializing in herbs and spices, serving customers across Belgium, France, the United Kingdom, and the Netherlands. The company provides a diverse range of herbs, spices, and seasonings tailored for private brands, catering to large retailers as well as food service and industrial clients. In addition to offering products under private labels, The Spice Factory also markets its own brand, ensuring a broad selection for various culinary applications.

Fire1 is a Dublin-based company dedicated to developing innovative therapeutic devices aimed at enhancing the quality of life for heart failure patients. The company has created a remote monitoring system that delivers real-time patient data and insights to healthcare providers. This technology facilitates the early detection of complications associated with heart failure, allowing for proactive interventions and ultimately leading to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to transform the management of heart failure and support better health management for patients.

Tibbloc is a French company that specializes in providing turnkey rental solutions for heating, domestic hot water, air conditioning, and cooling. Founded in 2007 and headquartered in Saint-Julien-de-Concelles, with additional offices in major cities such as Paris, Lyon, Nantes, Lille, and Marseille, Tibbloc serves a variety of sectors, including facility management, engineering, food and beverage, and manufacturing. The company's offerings encompass a range of services, including project studies, maintenance, transport and unloading, on-site installation and commissioning, fuel supply and management, and emergency services. By delivering customized solutions tailored to clients' technical requirements and budgets, Tibbloc effectively addresses the temporary heating, cooling, air treatment, steam, and compressed air needs of its customers.

Lupine is a company that offers repair services. They change the product in any way but reduce the impact on the environment caused by waste and, at the same time, protect wallet. They develop and produce lamps. The lamp includes all relevant components and the completed repair letter in a package.

Kivu Biosciences, based in San Francisco, is a biotechnology company specializing in the development of next-generation antibody-drug conjugates (ADCs) for cancer treatment. The company aims to deliver superior therapeutics and rapidly advance transformative assets, operating discreetly while focusing on its innovative pipeline.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company based in Schlieren, Switzerland, founded in 2014. The company specializes in the discovery and development of innovative immunotherapies aimed at enhancing cancer treatment and addressing autoimmune diseases. ImmunOs focuses on creating novel human immunomodulatory proteins that play a role in both innate and adaptive immunity. Their therapeutics are designed to exert direct anti-tumor effects by remodeling the tumor microenvironment, while also developing antibodies that inhibit the activation of specific HLA molecules linked to autoimmune conditions. Through its research and development efforts, ImmunOs aims to improve the lives of patients facing serious diseases.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Onera Health, Inc. specializes in sleep diagnostic solutions and services aimed at identifying sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and headquartered in Palo Alto, California, with a research and development office in Eindhoven, the Netherlands, the company utilizes advanced sleep diagnostic patch systems that collect and analyze sleep data. These innovative solutions are designed to enhance patient care by providing comprehensive sleep test data to healthcare professionals across various settings, thereby improving the management of sleep-related ailments and potentially benefiting other medical fields through remote monitoring of chronic conditions. Onera Health's mission is to improve the health and quality of life for individuals struggling with sleep issues while also contributing to cost reductions in healthcare.

ERS electronic GmbH is a manufacturer based in Munich, Germany, specializing in thermal wafer chuck systems for the semiconductor industry. Established in 1970, the company designs and produces a range of thermal solutions tailored for various testing applications. Its product lineup includes the AirCool3 modular chuck system, the PowerSense chuck system for high-wattage logic chips, and the WaferTherm chuck system for laboratory thermal testing. Additionally, ERS offers the AirCool3 Package Level thermal system for testing packaged devices and Aircool AC3 chucks for wafer temperature probing. The company is also capable of developing custom solutions to address specific thermal testing and processing challenges within the industry.

Witec is a Contract Design Manufacturer of high-tech equipment and high-end products.

Complement Therapeutics is a preclinical stage biotechnology company focused on addressing chronic diseases linked to the dysregulation of the complement system. The company has developed a precision medicine diagnostic platform that stratifies patients according to their complement-activation profiles. This innovative approach not only facilitates patient selection for future clinical trials but also serves as an efficacy biomarker, potentially enhancing medical treatment outcomes. By leveraging its platform methodology, Complement Therapeutics aims to improve the precision of treatments for patients suffering from conditions influenced by complement system dysregulation.

Mediar Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2019. It specializes in developing antibody-based therapeutics targeting key fibrotic mediator proteins involved in fibrosis, aiming to halt and potentially reverse this condition in chronically damaged organs. The company operates at the pre-clinical stage.

Fire1 is a Dublin-based company dedicated to developing innovative therapeutic devices aimed at enhancing the quality of life for heart failure patients. The company has created a remote monitoring system that delivers real-time patient data and insights to healthcare providers. This technology facilitates the early detection of complications associated with heart failure, allowing for proactive interventions and ultimately leading to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to transform the management of heart failure and support better health management for patients.

Paleo is a food ingredient company focused on developing innovative ingredients for plant-based foods, specifically targeting alternatives to meat and fish. The company utilizes precision fermentation to produce animal-free heme proteins that are GMO-free and replicate the sensory and nutritional properties of their animal-derived counterparts. By leveraging bioscience, Paleo aims to create ingredients that enhance the taste, texture, and appearance of plant-based products, making them more appealing to consumers. This commitment to sustainability allows businesses to offer alternatives that do not harm animals while meeting the growing demand for healthier and environmentally friendly food options.

JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogy™ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.

ImCheck Therapeutics is a biopharmaceutical company based in Marseille, France, that specializes in developing immunotherapeutics aimed at addressing severe unmet medical needs, particularly in the field of immuno-oncology. Founded in 2015, the company focuses on designing and developing immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules. These innovative therapies engage γ9δ2 T cells, a specific type of immune cell, to effectively treat various cancers, including breast, gastric, and ovarian cancers, as well as other solid tumors. Through its advanced research and development efforts, ImCheck Therapeutics seeks to provide next-generation immunotherapeutics for patients suffering from immune-related diseases.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company based in Schlieren, Switzerland, founded in 2014. The company specializes in the discovery and development of innovative immunotherapies aimed at enhancing cancer treatment and addressing autoimmune diseases. ImmunOs focuses on creating novel human immunomodulatory proteins that play a role in both innate and adaptive immunity. Their therapeutics are designed to exert direct anti-tumor effects by remodeling the tumor microenvironment, while also developing antibodies that inhibit the activation of specific HLA molecules linked to autoimmune conditions. Through its research and development efforts, ImmunOs aims to improve the lives of patients facing serious diseases.

Variass is a specialist in electronic manufacturing services (EMS) and system supply, focusing on the development and production of client-specific electronic and mechatronic products and systems. The company primarily serves the defense, medical, water, and industrial markets, emphasizing small to medium-sized series characterized by high variety and complexity. Variass offers a comprehensive range of services, including product and process development, industrialization, series production, assembly, logistics, and lifecycle management, ensuring reliable delivery and flexibility to meet the diverse needs of its clients.

BioConnection is a European contract manufacturer specializing in biopharmaceutical products. Established to serve small pharmaceutical companies, it offers access to both small-scale clinical batch production and large-scale commercial facilities. With expertise in development and manufacturing of active ingredients and end-products, BioConnection leverages its network, including Merck&Co's 85 years of experience, to provide comprehensive solutions for clients' drug development needs. Its services include sterile drug product development, freeze-drying at various scales, process validation, analytical support, clinical trial material services, and filling/finishing of products. As an independent intermediary, BioConnection acts as a one-stop shop for personalized medications, clinical trials, and commercial purposes.

Precirix is a biotechnology company based in Brussels, Belgium, focused on the development of radio-immunotherapeutic drugs aimed at treating cancer patients. Established in 2014, the company utilizes the unique properties of the camelid immune system to create targeted therapies. Its innovative approach involves using antigen-binding fragments to deliver therapeutic radioisotopes directly to specific receptors on cancer cells. This method allows for a more personalized treatment option, enhancing the effectiveness of cancer therapies while minimizing damage to healthy tissue. Precirix is dedicated to advancing the field of oncology through its specialized drug development, contributing to improved outcomes for patients with various types of cancer.

GSDI Group is a developer and supplier specializing in surface treatment and the installation of technical adhesive films. The company provides comprehensive solutions for renovation, thermal comfort, protection, and decoration, catering to clients in various sectors, including railway, building, and food. GSDI distinguishes itself by employing the largest installation force in Europe, consisting of 160 trained applicators who receive instruction at the company’s approved training center. In addition to adhesive films, GSDI offers products such as tarpaulins and varnishes, enabling clients to address everyday challenges effectively.

Topas Therapeutics GmbH, established in 2013 and based in Hamburg, Germany, is a biotechnology company specializing in the development of nanoparticle-based therapeutics. The company's core focus is to induce antigen-specific immune tolerance, utilizing the liver's natural immunology capabilities to treat autoimmune diseases, allergies, and anti-drug antibodies. Topas' proprietary platform, Topas Particle Conjugates, targets liver sinusoidal endothelial cells, enabling tolerance against blood-borne antigens. The company has several clinical-stage programs, including TPM203 for pemphigus vulgaris, and collaborations with pharmaceutical giants like Eli Lilly and Boehringer Ingelheim. Topas Therapeutics is backed by prominent investors such as Epidarex Capital, Gimv, EMBL Ventures, Evotec, and Boehringer Ingelheim Venture Fund.

Klotter specializes in the fields of energy technology, automation technology, lightning technology, and building technology.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Verkley is a company that specializes in the construction and maintenance of underground cable and pipeline networks, focusing on sectors such as energy, water, telecommunications, and public infrastructure. It provides comprehensive construction services tailored to meet the needs of network companies, industrial clients, and government entities. Verkley's expertise includes the laying, mounting, and testing of cables and pipelines for a variety of applications, including gas, water, electricity, telecommunications, heating networks, and public lighting. By emphasizing efficient practices, Verkley helps its clients minimize waste and reduce environmental impact.

Sofatutor GmbH is an edtech company based in Berlin, Germany, that operates an online learning platform aimed at K-12 pupils and students across Europe. Founded in 2008, Sofatutor offers a comprehensive suite of educational resources, including video lessons, practice problems, worksheets, and homework chat, spanning subjects such as mathematics, physics, English, chemistry, biology, and more. The platform serves students, teachers, and parents, providing tools to enhance learning and academic performance. In addition to video tutorials, Sofatutor features exercises and one-on-one tutoring sessions, empowering learners to engage with content effectively and prepare for exams. The platform is designed to facilitate a supportive learning environment, making education more accessible and interactive.

Kinaset Therapeutics is a therapeutics company dedicated to advancing innovative drugs aimed at addressing unmet medical needs, particularly in the field of respiratory diseases. The company specializes in developing novel therapeutics for patients suffering from intractable conditions, including severe asthma. By harnessing a distinctive approach to treatment, Kinaset aims to provide healthcare providers with less-invasive and more cost-effective alternatives for managing severe asthma. Through its commitment to addressing these challenging health issues, Kinaset Therapeutics seeks to significantly improve the quality of life for affected individuals.

SynOx Therapeutics is a clinical stage biopharmaceutical company based in Dublin, Ireland, established in 2019. The company focuses on the development of innovative therapies for cancer, particularly through its lead product, emactuzumab. This humanized monoclonal antibody specifically targets the CSF-1 receptor, aiming to deplete macrophages within tumor tissues. SynOx Therapeutics is dedicated to addressing the unmet clinical needs of patients suffering from diffuse tenosynovial giant cell tumors and other conditions associated with macrophage activity, ultimately striving to provide best-in-class treatment options that enhance patient quality of life. The company is backed by experienced investors with a strong track record in biopharmaceutical development.

Topas Therapeutics GmbH, established in 2013 and based in Hamburg, Germany, is a biotechnology company specializing in the development of nanoparticle-based therapeutics. The company's core focus is to induce antigen-specific immune tolerance, utilizing the liver's natural immunology capabilities to treat autoimmune diseases, allergies, and anti-drug antibodies. Topas' proprietary platform, Topas Particle Conjugates, targets liver sinusoidal endothelial cells, enabling tolerance against blood-borne antigens. The company has several clinical-stage programs, including TPM203 for pemphigus vulgaris, and collaborations with pharmaceutical giants like Eli Lilly and Boehringer Ingelheim. Topas Therapeutics is backed by prominent investors such as Epidarex Capital, Gimv, EMBL Ventures, Evotec, and Boehringer Ingelheim Venture Fund.

Televic specializes in the development and manufacturing of advanced communication systems tailored for specific sectors, including healthcare, education, railways, and conferences. The company provides a wide range of products such as digital on-board service networks, passenger information systems, visual information solutions, and entertainment systems, all designed to ensure seamless and interference-free communication. Televic aims to strengthen its position as a leader in these markets while pursuing opportunities for global growth.

AME is an independent developer and manufacturer of high quality electronic products located in the top technological region.

JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogy™ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.

General Fusion Inc., established in 2002 and headquartered in Burnaby, Canada, specializes in developing commercial Magnetized Target Fusion (MTF), a hybrid fusion method combining magnetic confinement and inertial confinement principles. The company focuses on creating utility-scale fusion power using its patent-pending MTF concept, which has the potential to provide clean, safe, and economical energy. General Fusion develops key subsystems such as plasma injectors, acoustic drivers, and liquid metal vortex compression tests to advance its MTF technology. Backed by a global syndicate of investors, industry leaders, and technology pioneers, General Fusion aims to demonstrate and commercialize its innovative fusion power plants by the end of the decade.

ImCheck Therapeutics is a biopharmaceutical company based in Marseille, France, that specializes in developing immunotherapeutics aimed at addressing severe unmet medical needs, particularly in the field of immuno-oncology. Founded in 2015, the company focuses on designing and developing immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules. These innovative therapies engage γ9δ2 T cells, a specific type of immune cell, to effectively treat various cancers, including breast, gastric, and ovarian cancers, as well as other solid tumors. Through its advanced research and development efforts, ImCheck Therapeutics seeks to provide next-generation immunotherapeutics for patients suffering from immune-related diseases.

iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Alro Group is a Belgium-based company specializing in the coating of plastic and metal parts for the automotive industry. Originally a small coating enterprise, it has expanded into a reputable group with multiple branches across Western and Central Europe. The company provides a range of coating services, including wet coating, electrocoating, and powder coating, and also offers assembly services. This diverse expertise allows Alro Group to meet the specific coating needs of its clients in the automotive sector, ensuring high-quality finishes for various metal and plastic products.

Smart Battery Solutions GmbH is a German company that specializes in the development and manufacturing of lithium-ion battery systems and charging technologies. Founded in 2010 and headquartered in Kleinostheim, the company offers a range of products, including unipower systems, LBP-Xell products, batteries, chargers, and cells. These products cater to various e-mobility applications such as e-bikes, e-scooters, watercraft, and drones, as well as stationary energy storage solutions for constant power supply needs. Smart Battery Solutions serves diverse sectors, including energy production, robotics, nautical science, and healthcare, providing intelligent energy storage systems that meet the demands of modern technology.

Precirix is a biotechnology company based in Brussels, Belgium, focused on the development of radio-immunotherapeutic drugs aimed at treating cancer patients. Established in 2014, the company utilizes the unique properties of the camelid immune system to create targeted therapies. Its innovative approach involves using antigen-binding fragments to deliver therapeutic radioisotopes directly to specific receptors on cancer cells. This method allows for a more personalized treatment option, enhancing the effectiveness of cancer therapies while minimizing damage to healthy tissue. Precirix is dedicated to advancing the field of oncology through its specialized drug development, contributing to improved outcomes for patients with various types of cancer.

La Comtoise specializes in the development and supply of customized cheese solutions tailored for the industrial food processing sector. The company produces a diverse array of processed cheese products intended for the food service industry, ensuring consistent physicochemical and organoleptic qualities. These cheese products are integrated into various prepared foods, such as breaded escalopes and grilled ham and cheese sandwiches, allowing clients to meet their specific product requirements.

Medi-Markt is the specialist for medical aids and care aids.

Medi Markt Service Nord Ost is a provider of medical aids in Germany, specializing in a range of healthcare products and services. With over a decade of experience, the company focuses on incontinence care, diabetes management, stoma care, enteral nutrition, and tracheostomy supplies, among other essential medical aids. It offers patients access to incontinence medications and products, diabetes monitoring, dietary consultations, and ostomy care solutions, aiming to support individuals in adapting to their health challenges. By delivering tailored medical supplies and professional services, Medi Markt Service Nord Ost addresses the specific needs of its clients, contributing to their overall well-being and quality of life.

Kind Technologies is a horticulture automation company that focuses on serving greenhouse growers and packing centers. It specializes in developing systems for internal logistics, sorting, packing, and inspection, utilizing advanced technologies such as computer vision and robotics. By integrating these technologies, Kind Technologies enables its clients to enhance productivity, minimize waste, and manage the growth of fruits, vegetables, and plants more effectively. The company's solutions aim to support sustainable practices in agriculture, allowing for more predictable and efficient operations within the horticulture sector.

Laser 2000 is an independent European supplier specializing in innovative laser and photonics solutions. With over three decades of experience, the company offers a wide range of products including lasers, light sources for material processing, measurement equipment, fiber optics, 3D imaging devices, optical power and energy meters, and cameras. Laser 2000 serves prominent companies and research institutes across various industries such as automation and sensor technology, optical communications, biotech and medicine, automotive, and aerospace. The company's long-standing relationships with customers and suppliers underscore its position as a pioneer in the photonics field.

Impact is a temporary employment agency for specialists in technics, construction and office work. IMPACT is a specialized temporary employment agency with its headquarters in Hasselt. Their main objective? By means of a personal approach, a clear focus, and a great deal of engagement and expertise, they aim to match employers with specialists who are looking for a job in the fields of technics, construction, or office work. Thus, they contribute to the successful growth of enterprises and to the professional satisfaction of the experts who found a job thanks to them.

France Thermes is an organization that oversees various subsidiaries focused on the hydrotherapy industry. It manages thermal resorts in Bagnoles de l'Orne, located in Normandy, and Châtel-Guyon in Auvergne, both of which have been under its supervision since January 1, 2017. The company specializes in therapeutic treatments utilizing natural thermal sources, offering water-based therapies designed to address conditions such as osteoarthritis and rheumatism. Through its healthcare spas and facilities, France Thermes aims to promote a healthy lifestyle for its patients by providing comprehensive therapeutic services in a serene environment.

Fire1 is a Dublin-based company dedicated to developing innovative therapeutic devices aimed at enhancing the quality of life for heart failure patients. The company has created a remote monitoring system that delivers real-time patient data and insights to healthcare providers. This technology facilitates the early detection of complications associated with heart failure, allowing for proactive interventions and ultimately leading to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to transform the management of heart failure and support better health management for patients.

Stiplastics S.A.S. specializes in the design, development, and manufacturing of medical devices for the healthcare sector, both in France and internationally. Established in 1985 and headquartered in Beauvoir-en-Royans, the company offers a diverse range of products, including distributor pumps, tamper-proof containers, caps, closures, cosmetic spatulas, nozzles, droppers, measuring scoops, and various packaging solutions. Additionally, it provides pharmaceutical packaging products, carrying cases for biological samples, and pillboxes. Stiplastics S.A.S. distributes its offerings through a comprehensive catalog, catering to the needs of the healthcare industry.

Wemas Absperrtechnik is a leading manufacturer in Germany specializing in integrated and certified solutions for road safety technology, primarily serving the infrastructure and construction markets. The company's extensive product lineup includes road shut-off devices such as safety barriers, fall arrestors, lights, footplates, and traffic cones. In addition to its core offerings, Wemas also produces various plastic products, including mortar baths, protective devices for the logistics sector, and equipment for equestrian sports. With a dedicated workforce of over 120 employees at its headquarters in Gütersloh, Wemas focuses on delivering high-quality products to wholesalers and service providers, ensuring traffic safety and customer satisfaction.

Cegeka is an information technology company that specializes in providing cloud computing, software development, cybersecurity, and digital transformation services. The company aims to assist businesses in navigating the complexities of the digital landscape by offering a range of solutions, including application management, data solutions, and digital workplace services. Cegeka's offerings are designed to enhance operational efficiency and competitive advantage, helping clients integrate digital tools for improved collaboration and streamlined processes. By focusing on these core services, Cegeka supports organizations in their efforts to thrive in an increasingly digital world.

Arseus Medical Group, established in 2002 and headquartered in Waalwijk, the Netherlands, is a leading distributor of medical equipment and consumables. The company supplies a wide range of products, including medical devices, disposables, hygiene and disinfection products, lab and testing materials, and surgery equipment, to hospitals, specialists, and other healthcare providers across the Benelux region. Arseus Medical Group focuses on providing efficient diagnostic and therapeutic solutions, patient monitoring systems, and supporting infrastructure to enhance the efficiency and quality of care. With strong brands, exclusive distribution agreements, and dedicated professional teams, the company differentiates itself by offering innovative, high-value solutions tailored to the needs of its clients.

MVZ Holding focusses on providing best in class primary medical care and has grown successfully by executing a disciplined expansion strategy. The company currently runs more than 25 medical practices in different regions in Switzerland and plans further expansion within the country.

ImCheck Therapeutics is a biopharmaceutical company based in Marseille, France, that specializes in developing immunotherapeutics aimed at addressing severe unmet medical needs, particularly in the field of immuno-oncology. Founded in 2015, the company focuses on designing and developing immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules. These innovative therapies engage γ9δ2 T cells, a specific type of immune cell, to effectively treat various cancers, including breast, gastric, and ovarian cancers, as well as other solid tumors. Through its advanced research and development efforts, ImCheck Therapeutics seeks to provide next-generation immunotherapeutics for patients suffering from immune-related diseases.

ALT Technologies, established in 1935, is a prominent manufacturer specializing in key components for airbags, particularly covers, wraps, and seals. The company supplies nearly all major airbag producers, securing multi-annual contracts that ensure its products are integrated into a wide range of well-known automobile brands globally. In addition to its focus on automotive safety, ALT Technologies also produces tailor-made die-cut and self-adhesive products for various industries, including durable goods. The company utilizes materials such as stainless steel and non-woven plastics to deliver innovative and cost-effective solutions, enabling clients to develop new product lines that meet evolving market demands.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Breath Therapeutics GmbH, based in Munich, Germany, with an additional office in Menlo Park, California, specializes in developing innovative drug-aerosol therapeutics aimed at treating bronchiolitis obliterans syndrome and other severe respiratory diseases. Founded in 2016 and operating as a subsidiary of Zambon S.p.A., the company focuses on creating novel formulations of existing drugs combined with advanced inhalation technologies. Their drug-device combinations are designed to deliver high concentrations of therapeutics directly to the lungs, enhancing efficacy while minimizing systemic exposure. This approach targets rare respiratory diseases with significant unmet medical needs, positioning Breath Therapeutics at the forefront of inhalation therapy advancements.

Itineris is a company that specializes in developing and implementing UMAX, a cloud-based customer information and customer relationship management solution tailored for the utilities sector. UMAX utilizes workflow automation and artificial intelligence to manage various aspects of utility operations, including meter reading, revenue collection, asset management, complex rate structures, and customer engagement initiatives. Built on the Microsoft Dynamics 365 platform and delivered through the Microsoft Azure Cloud, UMAX enhances operational efficiency and supports advanced customer engagement. Founded in 2003, Itineris has established a strong track record in software implementation, serving a diverse client base that includes notable organizations such as De Watergroep in Belgium, Eneco in the Netherlands, and the New York Department of Environmental Protection in the United States. The company's solutions are designed to empower utility professionals to navigate the evolving landscape of energy and water management effectively.

MEGA International is a company that specializes in providing digital transformation software and consulting services aimed at helping organizations manage enterprise complexity. With a focus on governance and compliance, MEGA International addresses challenges associated with IT complexity, regulatory requirements, and technological advancements. Their flagship software suite, HOPEX, offers a comprehensive solution for organizations seeking to enhance their operational governance and implement effective IT strategies. By leveraging their technology and expert advice, MEGA International enables businesses to improve agility, foster innovation, and optimize costs while managing risks. The company is recognized for its commitment to customer success, which drives its innovation and service offerings. MEGA International serves a diverse client base across over 40 countries, emphasizing its role in supporting organizations through successful digital transformation initiatives.

Acceo is an independent company that specializes in engineering, inspection, and certification services for buildings and large structures. It operates through various subsidiaries, offering a range of services including elevator engineering, inspection, and monitoring. Acceo conducts regulated accessibility audits and energy efficiency assessments, catering primarily to the hospital market and the commercial or administrative sectors. By providing expert advice on elevator design for both new and existing buildings, Acceo aids clients in improving the performance of their properties, reducing operating costs, and enhancing property value.

Spineart Geneva SA is a medical device company based in Geneva, Switzerland, specializing in innovative solutions for spine surgery. Founded in 2005, the company provides a comprehensive range of sterile packed implants and compact instrument sets designed for minimally invasive surgical procedures, motion preservation, fusion, biologics, and fracture treatments. Its product offerings include various types of pedicle screws, cervical plates, interbody devices, and motion devices such as disc prostheses. Additionally, Spineart develops biologics devices like synthetic osteoconductive gels and scaffolds. By introducing patented and clinically validated technologies, the company aims to enhance the efficiency and safety of surgical practices for spine surgeons and operating room teams, ultimately benefiting patients.

Summa is a Belgian company established in 1973, initially focused on assembling high-tech recording devices for precision optical lenses. The company transitioned into the vinyl imaging sector in 1987 by modifying pen-plotters for vinyl-cutting applications. Today, Summa is recognized as a global leader in the manufacturing of digital roll cutters and cutting equipment tailored for the printing and graphic design industry. Its product offerings include cutters, flatbed cutter systems, and finishing systems, which are designed to help clients optimize workflows and reduce human error, ultimately saving time and resources. Summa serves various markets, including signage, outdoor advertising, and aerospace.

Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

EndoStim Inc., established in 2009 and headquartered in Dallas, Texas, is a medical device company specializing in neurostimulation solutions for treating gastro-esophageal reflux disease (GERD). The company's primary product is a microstimulator that targets the lower esophageal sphincter muscle to restore normal function, providing long-term reflux control. EndoStim distributes its products globally, with a presence in Europe, Asia, and Latin America. Currently, it is conducting clinical trials to pursue FDA approval for this innovative treatment option.

Joolz is a Netherlands-based company that specializes in the design and manufacture of premium pushchairs. Known for their award-winning products, Joolz emphasizes quality and ergonomic design, creating stylish and distinctive strollers that cater to the needs of both children and parents. The company's offerings include features such as detachable cradles, hypoallergenic mattresses, and four-wheel suspension, ensuring durability and ease of use for consumers. Joolz is committed to promoting a sustainable and healthy lifestyle for young families, which is evident in their use of reusable packaging and initiatives like the Joolz Birth Forest. Through their innovative products and focus on sustainability, Joolz aims to inspire families to enjoy a positive and enriching life.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Topas Therapeutics GmbH, established in 2013 and based in Hamburg, Germany, is a biotechnology company specializing in the development of nanoparticle-based therapeutics. The company's core focus is to induce antigen-specific immune tolerance, utilizing the liver's natural immunology capabilities to treat autoimmune diseases, allergies, and anti-drug antibodies. Topas' proprietary platform, Topas Particle Conjugates, targets liver sinusoidal endothelial cells, enabling tolerance against blood-borne antigens. The company has several clinical-stage programs, including TPM203 for pemphigus vulgaris, and collaborations with pharmaceutical giants like Eli Lilly and Boehringer Ingelheim. Topas Therapeutics is backed by prominent investors such as Epidarex Capital, Gimv, EMBL Ventures, Evotec, and Boehringer Ingelheim Venture Fund.

Contraload is a rapidly expanding company based in Belgium, specializing in the pooling and rental of plastic pallets and containers. With over a decade of experience, the company manages nearly one million assets that are actively utilized across Europe. Contraload offers a diverse range of plastic pallets and intermediate bulk containers (IBCs) tailored to various supply chains, particularly in the food and fast-moving consumer goods (FMCG) sectors. The company serves prominent global clients such as Unilever and Nestle, addressing their stringent quality and hygiene standards while minimizing the risk of foreign body contamination. By providing cost-effective solutions, Contraload enables businesses to connect efficiently with suppliers and customers, allowing them to concentrate on their core operations.

Itho Daalderop Group B.V. is a manufacturer and supplier of HVAC products, specializing in solutions for heating, domestic hot water, ventilation, and control engineering. Established in 1880 and based in Tiel, the Netherlands, the company develops a range of products including central heating systems, heat pumps, solar boilers, kitchen boilers, and air purification systems. It serves both residential and commercial clients, offering advisory services to governments, corporations, and construction companies on new builds, renovations, and replacements. With additional locations in Schiedam, Etten-Leur, the United Kingdom, and Sint-Niklaas, Belgium, Itho Daalderop focuses on creating innovative and energy-efficient solutions that promote a healthy and comfortable indoor climate. The company operates as a subsidiary of Klimaatgarant B.V. since 2016.

Legallais is a prominent distributor of hardware and building products in the French market, specializing in ironmongery, plumbing, and electrical supplies. The company caters primarily to craftsmen, building operators, and maintenance firms, providing a comprehensive range of high-quality offerings. Renowned for its exceptional service, Legallais ensures a high level of product availability and offers multiple ordering options, including mobile, online, and mail. Its automated logistics system guarantees delivery within 24 hours, reinforcing its position as a market leader in customer service and efficiency.

Brakel BV specializes in manufacturing daylight access, fire safety, and ventilation solutions, including skylights, rooflights, glass louvres, facades, and various ventilation systems. Established in 1977 and based in Uden, the Netherlands, the company has maintained its position as a market leader for over 35 years, serving diverse sectors such as distribution and logistics, industry, office buildings, education, public buildings, and healthcare, both in Europe and internationally. Brakel BV also offers maintenance services for its systems, ensuring their optimal performance. Its products are distributed through a certified partner network and its project organizations in the Netherlands, Belgium, and the United Kingdom. As of late 2017, Brakel BV operates as a subsidiary of Kingspan Group plc.

Equipe Zorgbedrijven Nederland, based in Eindhoven, operates a network of specialized clinics across the Netherlands. These clinics focus on providing medical treatment in areas such as hand and wrist surgery, cosmetic surgery, dermatology, phlebology, and proctology, aiming to cure patients effectively.

Biom'Up S.A. is a French company specializing in the development and commercialization of innovative hemostatic products and absorbable medical devices based on patented biopolymer and collagen technologies. Founded in 2005 and headquartered in Saint-Priest, France, Biom'Up designs and manufactures medical devices aimed at improving surgical outcomes across various specialties, including orthopedic, spinal, cardiac, general, and maxillofacial surgeries. Its flagship products, such as HEMOBLAST bellows and associated laparoscopic applicators, are clinically proven to enhance patient healing by facilitating guided regeneration of soft tissues and bone. The company markets its products primarily in Europe and the United States, contributing significantly to the field of biosurgery.

JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogy™ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.

CoScale is a developer of a comprehensive performance monitoring platform tailored for production environments. The platform continuously tracks servers, containers, and applications, providing insights into their effects on user experience and key business metrics. By employing automated anomaly detection and contextual insights, CoScale simplifies the monitoring and troubleshooting processes for its users, enabling proactive responses to performance issues that could adversely impact business outcomes. The platform is designed for use by DevOps engineers, application owners, and business professionals, all of whom aim to enhance digital performance by ensuring faster and more reliable websites and applications. This ultimately leads to improved user experiences and increased conversion rates.

Itineris is a company that specializes in developing and implementing UMAX, a cloud-based customer information and customer relationship management solution tailored for the utilities sector. UMAX utilizes workflow automation and artificial intelligence to manage various aspects of utility operations, including meter reading, revenue collection, asset management, complex rate structures, and customer engagement initiatives. Built on the Microsoft Dynamics 365 platform and delivered through the Microsoft Azure Cloud, UMAX enhances operational efficiency and supports advanced customer engagement. Founded in 2003, Itineris has established a strong track record in software implementation, serving a diverse client base that includes notable organizations such as De Watergroep in Belgium, Eneco in the Netherlands, and the New York Department of Environmental Protection in the United States. The company's solutions are designed to empower utility professionals to navigate the evolving landscape of energy and water management effectively.

United Dutch Breweries B.V. is an independent beer producer and distributor based in Breda, the Netherlands, founded in 1968. The company specializes in the production and supply of various beer types, including lagers, non-alcoholic malt beverages, dark malt beverages, ciders, and fruit beers. United Dutch Breweries owns several heritage brands such as Oranjeboom, 3 Horses, Royal Dutch, and Atlas. In addition to its core offerings, the company also markets specialty brews, including stout beers and non-alcoholic options, catering to a diverse customer base. Their products are distributed globally through both on-trade and off-trade channels, ensuring a wide reach in the beverage market.

Teads, Inc. is a company that specializes in creating enterprise software for digital branding, primarily through its video advertising supply side platform (SSP) designed for publishers and brands. Founded in 2012 and headquartered in New York, with additional offices in Chicago and California, Teads enables clients to generate outstream video advertising inventory and effectively monetize it via their sales forces, third parties, and programmatic buying. The platform offers an omnichannel solution for programmatic digital advertising across a global network of premium media, integrating technologies for buy-side, sell-side, creative, and data optimization. By providing brand-safe and engaging ad experiences, Teads reaches billions of unique users, enhancing the effectiveness of digital advertising transactions and delivering sustainable business outcomes for advertisers and agencies.

EcoChem International is a manufacturer and distributor of eco-friendly flame retardant additives, primarily serving the building and construction, transportation, and electronic sectors. The company's additives are integrated into materials such as wood, insulation, textiles, and plastics to inhibit, suppress, or delay the production of flames and smoke during a fire. Headquartered in Olen, Belgium, EcoChem operates two production facilities located in Willebroek, Belgium, and Offenbach, Germany. With a commitment to providing economically viable solutions that prioritize environmental protection, EcoChem serves clients across 25 countries.

Well Services Group is a comprehensive service provider for the oil and gas industry, catering to both onshore and offshore operations. The company specializes in cleaning and regenerating existing oil and gas wells using coiled tubing technology. In addition to well maintenance, it offers installation services for plugs and measurement equipment, ensuring efficient and reliable operations. Well Services Group utilizes advanced equipment and draws on the expertise of its personnel to deliver high-quality services tailored to the needs of its clients in the international oil, gas, petrochemical, and energy sectors. Its flexibility as an operating company allows it to respond swiftly to customer requirements, enhancing overall service delivery.

Mackevision Medien Design GmbH is a leading company in the field of Computer Generated Imagery (CGI), based in Stuttgart, Germany. Specializing in data-driven 3D visualization, animation, and visual effects, Mackevision produces high-quality image and film material, as well as interactive applications. The company offers a comprehensive range of services, including post-production for advertising films and visual animations. Its expertise extends to various applications such as online product configurators, digital and print catalogs, virtual showrooms, point-of-sale kiosks, and augmented and virtual reality experiences. Mackevision oversees the entire CGI process, from data preparation to creative design, ensuring the delivery of innovative and effective visual solutions.

Launched in 2007 by entrepreneur and mother of five Nathalie Christen-Genty, MELIJOE.COM is the world’s premier online fashion e-tailer for children ages 0-16. Featuring the latest in childrenswear trends inspired directly by adult runways, MELIJOE.COM is home to some of the industry’s most sought-after labels in kid’s fashion. MELIJOE.COM is above all an international brand, featuring 100% authentic products, speedy worldwide shipping and a website translated in six languages. Thanks to a developed editorial strategy and magazine-inspired web layout, MELIJOE.COM doubles as a digital news outlet for children’s fashion with Le Magazine, and between exclusive shopping edits, childrenswear news, trend reports and in-house photo shoots, MELIJOE.COM is an extra-large world of digital fashion for the smallest of fashionistas.

Thinkstep AG, established in 1991 and headquartered in Leinfelden-Echterdingen, Germany, specializes in sustainability software, data, and consulting services. It offers a suite of products including life cycle assessment tools, corporate sustainability solutions, energy management systems, and supply chain transparency platforms. Thinkstep serves over 2,000 clients worldwide, including 40% of the Fortune 500, helping them achieve operational excellence, product innovation, brand value, and regulatory compliance. With a global presence in 19 countries, the company operates as a subsidiary of Sphera Solutions, Inc.

Ablynx is a biopharmaceutical company focused on discovering and developing Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These Nanobodies are designed to treat serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. The company currently has around 25 projects in its pipeline, with five Nanobodies in clinical development. Ablynx's products aim to combine the advantages of conventional antibodies and small chemical molecules, offering patients innovative therapeutic options that can significantly impact society.

JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogy™ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.

Wolf Group is a manufacturer and distributor of women's lingerie, specializing in a diverse range of products, including plus-size options. The company operates primarily under several proprietary brands, including Rosy, Sans-Complexe, Billet Doux, Oups, and Jardin Secret. Wolf Group is committed to delivering fashionable and affordable lingerie, emphasizing quality support, meticulous finishing, and the use of premium fabrics and cuts. In addition to its in-house brands, the company also collaborates with major retailers and prestigious international brands to design and manufacture exclusive lingerie collections.

Transdev is a public transportation operator that focuses on providing comprehensive and accessible mobility solutions. The company manages a variety of transport services, including bus networks, long-haul coaches, rail, marine transportation, and airport facilities. By offering multi-modal transport options, Transdev enhances the commuting experience for passengers, ensuring safety and comfort. The company's operations emphasize local decision-making and customer engagement, allowing it to respond effectively to the needs and expectations of its clients. Transdev also incorporates innovative features such as applications that combine different transport modes and contactless payment systems, thereby facilitating seamless travel. Supported by major shareholders, Transdev is committed to delivering high-quality services while continuously seeking improvements to enhance the overall passenger experience.

Covagen is a biopharmaceutical company specializing in the development of bispecific therapeutics known as FynomAbs, which are created by genetically fusing human Fynomer binding proteins to antibodies. This innovative approach allows Covagen to design therapeutics with unique architectures, enhancing their efficacy in treating inflammatory diseases and cancer. The company aims to explore novel biological pathways with each product candidate, with its lead FynomAb, COVA322, currently being developed for inflammatory conditions such as rheumatoid arthritis and psoriatic arthritis. Founded in 2007 as a spin-off from ETH Zurich, Covagen has established strategic collaborations, notably with Mitsubishi Tanabe, to advance its drug development initiatives. The company is supported by a diverse group of investors committed to its research and therapeutic programs.

Eurocept is a healthcare company based in Ankeveen, the Netherlands, founded in 2001 by CEO Mike van Woensel. The company specializes in the registration, marketing, distribution, and sale of specialty medicines across various fields, including anesthetics, psychiatry, urology, pediatrics, and infectious diseases through its Eurocept Pharmaceuticals division. Additionally, Eurocept Homecare offers medical specialist homecare services, focusing on outpatient medical technology for the administration of medicine and nutrition. Eurocept aims to simplify the treatment relationship between medical practitioners and patients, providing comprehensive services that encompass pharmacovigilance, hospital account management, and support for pharmaceutical companies in meeting their medicinal and nursing care needs.

Almaviva Santé is a private hospital group based in Puyrucard, France, founded in 2007 and headquartered in Marseille. The company operates a network of hospitals and health care clinics, offering a wide range of medical and surgical treatments across various specialties, including orthopedics, ophthalmology, cardiology, and urology. Almaviva Santé is committed to providing comprehensive care that prioritizes both safety and comfort for its patients.

Endosense is a medical technology company dedicated to enhancing the efficacy, safety, and consistency of catheter ablation procedures used to treat cardiac arrhythmias. The company developed the TactiCath, the first and only force-sensing ablation catheter that provides physicians with a real-time and objective measure of contact force during ablation. The TactiCath received the CE mark in May 2009 and has undergone extensive pre-clinical and clinical testing, establishing a strong evidence base for the feasibility and safety of contact force sensing in catheter ablation. Endosense's innovations aim to improve patient outcomes and streamline ablation procedures in the field of cardiology.

NovoPolymers NV is a company focused on creating sustainable solutions tailored for the photovoltaic market. It specializes in the development and production of front and back encapsulants that protect solar cells. These encapsulants are designed to enhance the power output of both crystalline silicon and thin-film solar modules, thereby adding value across the photovoltaic supply chain. Through its innovative products, NovoPolymers aims to contribute to the advancement of renewable energy technologies.

JenaValve Technology, Inc. is a medical device company specializing in the design, development, and manufacturing of transcatheter aortic valve replacement (TAVR) systems for patients with severe aortic regurgitation and aortic stenosis. Founded in 2006 and headquartered in Irvine, California, with additional locations in Munich, Germany, and Leeds, United Kingdom, the company focuses on providing innovative solutions for high-risk patients who may not be suitable candidates for traditional surgical aortic valve replacement. The company's flagship product, the Trilogy™ Heart Valve System, received CE Mark approval in May 2021 and is notable for its dual-disease treatment capabilities. JenaValve's TAVR systems feature a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame, designed to engage with the native valve structures for optimal performance. The company has also received Breakthrough Device Designation from the U.S. Food and Drug Administration to facilitate the review of its pivotal trial for the Trilogy Heart Valve System in the United States.

Complix is a biopharmaceutical company dedicated to the discovery and development of Alphabodies™, a novel class of therapeutics that provide distinct advantages over traditional protein-based treatments. These Alphabodies™ exhibit high affinity binding to a diverse array of disease targets, particularly those that are challenging for conventional antibodies to access. The company focuses on developing its pipeline of Alphabody therapeutics to address intracellular disease targets integral to conditions such as cancer, autoimmunity, and viral diseases. By merging the targeted potency of biologics with the stability and cell-penetrating capabilities of small molecules, Complix aims to overcome the limitations associated with conventional antibodies and small molecule drugs, thereby providing innovative solutions for patients facing intractable health issues.

Luciad is a provider of high-performance geospatial software tools designed to support mission-critical operations across various sectors, including public safety, smart cities, and defense. The company's applications facilitate rapid application development and enhance user experience through advanced visual analytics, enabling users to harness real-time location intelligence. This functionality allows for the creation of intuitive command and control systems, essential for safeguarding critical assets and making informed decisions based on dynamic information. Additionally, Luciad offers software solutions that integrate diverse data types with geographical information, including maps, satellite imagery, and terrain elevation, thereby laying the groundwork for next-generation geospatial systems.

Marco Vasco SAS is a travel agency based in Paris, France, specializing in tailor-made journeys and adventure travel across various global destinations, including Asia, Africa, the Americas, and Europe. Founded in 2005, the company offers personalized trip planning services, focusing on unique experiences and local insights. Marco Vasco provides clients with detailed itineraries, destination guides, and curated activities, making it easier for travelers to explore diverse environments, from urban settings to tropical jungles. The company has established itself as a leader in the online custom holidays market and has maintained profitability since 2010. Marco Vasco also operates an office in Shanghai, China, further extending its reach in the travel sector. In 2017, it became a subsidiary of Société du Figaro, SAS.

Lampiris N.V., founded in 2003 and based in Liège, Belgium, is an independent supplier of electricity and gas, serving both private individuals and businesses. The company has been active in the Belgian energy market since 2005 and has established itself as the third-largest supplier in the residential sector, with over a million accounts. In addition to energy supply, Lampiris offers various energy services, including insulation, furnace maintenance, and heating solutions using wood and pellets, as well as smart thermostats. As of September 2016, Lampiris operates as a subsidiary of Elf Aquitaine S.A.

Multiplicom is a company that specializes in the development of molecular diagnostics products specifically tailored for medical genetics. It manufactures molecular diagnostic kits that facilitate the collection of genetic information, allowing for early identification of congenital defects during pregnancy. By focusing on effective, affordable, and personalized medicine, Multiplicom aims to enhance patient care through advanced clinical laboratory-based tests. Its products are designed to empower healthcare providers and patients with critical genetic insights, contributing to more informed treatment decisions.

McPhy Energy S.A. is a French cleantech company based in La Motte, established in 2008. It specializes in developing and supplying equipment for hydrogen production, storage, and distribution, catering to the hydrogen energy, zero-emission mobility, and industrial hydrogen markets globally. The company's product portfolio includes alkaline electrolyzers that facilitate hydrogen production in various capacities, as well as innovative solid-state hydrogen storage solutions. Additionally, McPhy designs and manufactures hydrogen refueling stations and integrated hydrogen solutions, positioning itself as a key player in the transition towards sustainable energy systems.